Evers Pharmacy Inc v. OptumRx, Inc.

CourtDistrict Court, S.D. Illinois
DecidedJanuary 17, 2023
Docket3:22-cv-02156
StatusUnknown

This text of Evers Pharmacy Inc v. OptumRx, Inc. (Evers Pharmacy Inc v. OptumRx, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Evers Pharmacy Inc v. OptumRx, Inc., (S.D. Ill. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS

EVERS PHARMACY INC., d/b/a ) DAUBER PHARMACY, et. al., ) ) Plaintiffs1, ) ) vs. ) Case No. 22-cv-2156-DWD ) OPTUMRX, INC., successor by merger ) To Catamaran Corporation, and ) OPTUMRX, INC. in its own right, ) ) Defendant. )

MEMORANDUM AND ORDER

DUGAN, District Judge:

Now before the Court is Defendant’s Motion to Dismiss for Lack of Personal Jurisdiction (Doc. 20), Plaintiffs’ Motion to Remand (Doc. 23), Plaintiffs’ Motion for Discovery (Doc. 31), and Defendant’s Motion for Hearing (Doc. 59). Background On August 2, 2022, Plaintiffs, consisting of 91 independently owned pharmacies located throughout the United States filed a complaint against Defendant OptumRX, Inc. in the Circuit Court of St. Clair County, Illinois (Doc. 1-1). As alleged in the Complaint, Plaintiffs are small-business, independent pharmacies throughout the United States (Doc. 1-1, ¶ 93). Plaintiffs are specifically alleged to be citizens of Arizona, California, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, Mississippi, New York, North

1Plaintiffs include 91 corporate pharmacies. Each Plaintiff is more fully described on the docket sheet. To assist with the efficiency and organization of these claims, the Court FINDS it appropriate to use an abbreviate case caption as this time. Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, and Wyoming (Doc. 1-1, ¶¶ 1-91). Defendant is a

California corporation, with its principal place of business in California, and a wholly owned subsidiary of United Health Corporation (Doc. 1-1, ¶ 94). In July 2015, Defendant acquired and merged with the Illinois based Catamaran Corporation, which was headquartered in Schaumburg, Illinois (Doc. 1-1, ¶ 95). According to Plaintiffs, following the merger and until at least 2020, Defendant paid claims using two sets of systems (Doc. 1-1, ¶¶ 96-97). For health plans which had

contracted with Catamaran, claims were processed and paid in Illinois using the legacy Catamaran systems and personnel in Illinois (Doc. 1-1, ¶ 96). For the Optum line of business, claims were processed through Optum’s pre-existing facilities in California and Minnesota (Id.). Plaintiffs seek redress against Defendant for alleged breaches of contract and violations of state and federal laws related to Defendant’s reimbursement practices

for prescription drugs (Doc. 1-1). On September 14, 2022, Defendant removed the case to this Court pursuant to 28 U.S.C. § 1332(a) asserting diversity jurisdiction (Doc. 1). The parties do not dispute that the amount in controversy requirement is satisfied here. However, complete diversity of citizenship does not appear on the face of the Complaint. Indeed, Defendant and one

Plaintiff, KM Network, Inc., d/b/a Courtyard Pharmacy are both citizens of California (Doc. 1, ¶ 13; Doc. 1-1, ¶¶ 44, 94). Nevertheless, Defendant asks the Court to ignore KM Network, Inc.’s citizenship for subject-matter jurisdiction purposes (Doc. 1, ¶ 13). Defendant argues that KM Network’s claims have been misjoined because the Court lacks personal jurisdiction over KM Network’s claims and asks the Court to dismiss those claims (Doc. 1, ¶ 13). Plaintiffs disagree and move to remand (Doc. 23; Doc. 24).

Defendant also moves to dismiss Plaintiffs’ Complaint for improper venue, lack of personal jurisdiction, and a failure to state a claim (Doc. 20). Defendant argues that Plaintiffs’ contracts include a forum-selection clause that require all disputes to be arbitrated in either California or Minnesota (Doc. 20, pp. 2, 4).2 Alternatively, Defendant asks that three categories of claims be dismissed for lack of personal jurisdiction.3 Those claims include:

(1) The claims of at least five out-of-state Plaintiffs, including KM Network, who have no connection to Illinois or Defendant’s purported contacts in Illinois (Doc. 20, p. 8; Doc. 1, p. 24), and

(2) The claims of out-of-state Plaintiffs that were submitted: (a) prior to Defendant’s merger with Catamaran in July 2015 because Defendant had no connection to Illinois prior to this time, and (b) after February 2018 because Defendant no longer processed claims or had personnel in Illinois after February 2018 (Doc. 20, p. 10).4

Defendant categorizes Plaintiff KM Network, Inc.’s claims as those of a non-Illinois Plaintiff that submitted claims after February 28, 2018 (Doc. 20-4, ¶ 6).

2 Defendant has filed petitions to compel arbitration against nearly all the Plaintiffs in this matter in the Central District of California and the California Superior Court (Doc. 20, p. 3) (citing OptumRx, Inc. v. A & S Drugs LLC, et al., No. 8:22-cv-00468-FLA (C.D. Cal.); OptumRx v. Odedra Enters., Inc., et al., No. 30-2022- 01252611-CU-PT-CJC (Cal. Super. Ct.)). Defendant represents that its petitions are still pending. 3 Defendant denies that the Court has general personal jurisdiction over it but concedes that the Court may have specific personal jurisdiction over it for some of Plaintiffs’ Illinois-related claims (Doc. 1, pp. 26-27; Doc. 20, p. 9). 4 According to Christian Bongartz, Defendant’s Vice President of Technology, Defendant has processed all claims adjustments since February 2018 in Minnesota (Doc. 20-3, p. 3). However, Defendant does not indicate when all “personnel” may have left Illinois. Instead, Defendant’s 2022 Pharmacy Provider Manual continues to list the address “1600 McConnor Parkway, Schaumburg, Illinois” as the contact address for requesting copies of “previously sent Pharmacy Communications.” (Doc. 21-1, p. 218). The parties further disagree as to which jurisdictional inquiry the Court should decide first. Defendant asks that the Court resolve its motion to dismiss prior to ruling

on Plaintiffs’ motion to remand because the personal jurisdiction inquiry is more straightforward (Doc. 1, pp. 27-28) (citing Ruhrgas AG v. Marathon Oil Co., 526 U.S. 574, 588 (1999)). Whereas Plaintiffs ask the Court to rule on its Motion to Remand first (Doc. 24). Alternatively, Plaintiffs move to conduct jurisdictional discovery prior to the Court ruling on Defendant’s Motion to Dismiss (Doc. 31). Defendant opposes the Motion for Jurisdictional Discovery (Doc. 39), and further asks that the Court conduct a hearing on

Plaintiff’s Motion for Remand (Doc. 59). Plaintiffs oppose Defendant’s request for a hearing (Doc. 60). Discussion Federal courts have “leeway ‘to choose among threshold grounds for denying audience to a case on the merits.’” See Sinochem Int'l Co. v. Malaysia Int'l Shipping Corp.,

549 U.S. 422, 431 (2007) (citing Ruhrgas AG, 526 U.S. at 585, Steel Co. v. Citizens for a Better Env't, 523 U.S. 83, 100–101 (1998)). Thus, the Court is permitted to resolve underlying personal jurisdiction questions before first resolving issues of subject matter jurisdiction. Here, the Court finds that the question of its subject-matter jurisdiction to be the most straight-forward analysis. See Ruhrgas AG, 526 U.S. at 587–88 (if subject-matter

jurisdiction involves “no arduous inquiry,” then “both expedition and sensitivity to state courts' coequal stature should impel the federal court to dispose of that issue first”). Thus, the Court will resolve Plaintiffs’ Motion to Remand first. In doing so, the Court DENIES Defendant’s Motion for Hearing (Doc. 59).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ruhrgas Ag v. Marathon Oil Co.
526 U.S. 574 (Supreme Court, 1999)
Jane Doe v. Allied-Signal, Inc.
985 F.2d 908 (Seventh Circuit, 1993)
Craig Garbie v. Daimler Chrysler Corp.
211 F.3d 407 (Seventh Circuit, 2000)
Schur v. L.A. Weight Loss Centers, Inc.
577 F.3d 752 (Seventh Circuit, 2009)
Cassens v. Cassens
430 F. Supp. 2d 830 (S.D. Illinois, 2006)
CC Industries, Inc. v. Ing/Reliastar Life Insurance
266 F. Supp. 2d 813 (N.D. Illinois, 2003)
Steel Co. v. Citizens for a Better Environment
523 U.S. 83 (Supreme Court, 1998)
Jeremy Meyers v. Oneida Tribe of Indians of Wi
836 F.3d 818 (Seventh Circuit, 2016)
Kathryn Collier v. SP Plus Corporation
889 F.3d 894 (Seventh Circuit, 2018)
Reeves v. Pfizer, Inc.
880 F. Supp. 2d 926 (S.D. Illinois, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Evers Pharmacy Inc v. OptumRx, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/evers-pharmacy-inc-v-optumrx-inc-ilsd-2023.